
[Cancer Research 64, 6791-6796, September 15, 2004]
© 2004 American Association for Cancer Research
Functional Interaction between Tumor Suppressor Menin and Activator of S-Phase Kinase
Robert W. Schnepp1,
Zhaoyuan Hou1,
Haoren Wang1,
Clark Petersen1,
Albert Silva1,
Hisao Masai2 and
Xianxin Hua1
1 Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania; and 2 Department of Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
 |
ABSTRACT
|
|---|
Multiple endocrine neoplasia type I (MEN1), a hereditary tumor syndrome, is characterized by the development of tumors in multiple endocrine organs. The gene mutated in MEN1 patients, Men1, encodes a tumor suppressor, menin. Overexpression of menin leads to inhibition of Ras-transformed cells. However, it is unclear whether menin is essential for repression of cell proliferation, and if it is, how it inhibits cell proliferation. Here, we show that targeted disruption of the Men1 gene leads to enhanced cell proliferation, whereas complementation of menin-null cells with menin reduces cell proliferation. Moreover, menin interacts with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex that is crucial for cell proliferation, but does not appear to alter Cdc7 kinase activity in in vitro kinase assays. We identify the COOH terminus of menin as the domain that mediates the specific interaction with ASK. Notably, wild-type menin completely represses ASK-induced cell proliferation, although it does not obviously affect the steady-state cell cycle profile of ASK-infected cells. Interestingly, disease-related COOH-terminal menin mutants that do not interact with ASK completely fail to repress ASK-induced cell proliferation. Together, these findings demonstrate a functional link between menin and ASK in the regulation of cell proliferation.
 |
INTRODUCTION
|
|---|
Multiple endocrine neoplasia type I (MEN1) is a hereditary tumor syndrome that is characterized by the development of tumors in multiple endocrine organs including the pituitary, parathyroids, and ß-islet cells (1
, 2)
. The gene whose mutation is responsible for MEN1, Men1, encodes a protein of 610 amino acid residues, menin (3)
. Mice heterozygous for Men1 knockout develop parathyroid, pituitary, and pancreatic ß-islet tumors, (4, 5, 6, 7, 8)
largely recapitulating human MEN 1 syndrome. Ectopic expression of menin represses proliferation and tumorigenesis of Ras-transformed NIH3T3 cells and insulinoma cells (9
, 10)
. Reduction of menin expression by RNA interference in human fibroblasts enhances expression of telomerase (11)
. In addition, menin is critical for TGF-ßinduced inhibition of cell proliferation in pituitary tumor-derived cells (12)
. These findings suggest that menin regulates cell proliferation. However, it is unclear whether menin is essential for regulation of cell proliferation and whether targeted disruption of Men1, which is similar to loss of heterozygosity in the Men1 locus in MEN1-associated tumors, affects cell proliferation.
Menin interacts with the transcription factors JunD and nuclear factor-
b and represses their activation of gene transcription (13, 14, 15)
. Additionally, menin interacts with RPA2, a component of single-stranded DNAbinding protein involved in DNA repair and replication (16)
. Recently, we found that menin interacts with FancD2, a nuclear protein that plays a critical role in maintaining genome stability in concert with breast cancerassociated gene (Brca1; ref. 17
). To better understand the role of menin in regulating cell proliferation, we used affinity chromatography coupled with mass spectrometry analysis to isolate additional menin-interacting proteins. We find that menin interacts with activator of S-phase kinase (ASK), an essential component of the Cdc7/ASK kinase complex (18
, 19)
, which plays a critical role in DNA replication in part by regulating the function of the MCM complex. ASK and cdc7 are essential for cell proliferation. Thus, regulation of ASK by menin may be a means of repression of cell proliferation.
Here, we show that targeted disruption of menin enhances cell proliferation, whereas complementation with menin inhibits cell proliferation. Moreover, we identify ASK as a novel menin-interacting protein and find that the COOH terminus of menin specifically interacts with ASK. We demonstrate that ASK induces a modest yet consistent increase in cell proliferation but that wild-type menin inhibits this increase. Importantly, two disease-related mutations in the COOH terminus of menin not only block the menin-ASK interaction, but also fail to inhibit ASK-induced cell proliferation. Collectively, these results link menin to ASK in the regulation of cell proliferation.
 |
MATERIALS AND METHODS
|
|---|
Plasmid Construction.
Oligonucleotides were synthesized by Integrated DNA Technologies, Inc. (Coralville, IA). To generate constructs expressing various glutathione S-transferase (GST)-menin fusion proteins, human menin cDNA (20)
was amplified by PCR and cloned into the BamHI/NotI site of pGEX6-3 (Amersham Biosciences, Piscataway, NJ). To generate Flag-tagged ASK, pF-ASK, human ASK cDNA was amplified with a pair of primers containing a BclI and a NotI site, respectively, and inserted into the BamHI and NotI site of pcDNA3-Flag (21)
. Generation of recombinant retroviruses expressing wild-type or mutant menin is as described previously (17
, 22)
.
Isolation of Menin-Interacting Proteins.
Procedures for isolating menin-interacting proteins are as described previously except for several modifications (17)
. Human embryonic kidney 293 cells were stably transfected with either vector or pcDNA3-F-menin. Cells were lysed in high-salt lysis buffer by Dounce homogenization, and samples were diluted with lysis buffer without NaCl, yielding a final concentration of 150 mmol/L NaCl. The diluted samples were centrifuged at 105 x g to remove insoluble debris, and the supernatant was incubated with equilibrated agarose beads coupled with an anti-Flag antibody (M2; Sigma, St. Louis, MO) at 4°C for 2 hours. The beads were thoroughly washed with lysis buffer containing 200 mmol/L NaCl and then incubated at 4°C for 20 minutes with elution buffer containing 0.5 mg/mL Flag peptide. The purified proteins from the control cells and the cells expressing F-menin were separated by SDS-PAGE, stained with a Colloidal Blue Staining kit (Invitrogen, Carlsbad, CA), and excised under a sterile hood. The peptide sequences from these proteins were identified using mass spectrometry at the Proteomics Core Facility at the University of Pennsylvania.
Cell Culture.
Human embryonic kidney 293 and 293T cells were cultured in Dulbeccos modified Eagles medium supplemented with 10% (v/v) fetal calf serum, penicillin (100 units/mL), and streptomycin (100 µg/mL; ref. 23
). The cells were transfected using the calcium phosphate precipitation method as described previously (21)
. Menin-null and menin-complemented murine embryonic fibroblasts, isolated and immortalized as described previously (17)
, were cultured in Dulbeccos modified Eagles medium supplemented with 10% fetal bovine serum, 1x nonessential amino acid mixtures, L-glutamine, and antibiotics (MEF medium).
Immunoprecipitation, Glutathione S-TransferasePulldown, and Immunoblotting Analysis.
Transfected 293 cells were lysed with cell lysis buffer [50 mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4), 100 mmol/L NaCl, 1 mmol/L EDTA and EGTA, 0.4% NP40, 20 mmol/L ß-glycerophosphate, and 2 x Protease Inhibitor Mixture Complete (Boehringer Mannheim)] as described previously (24)
. Lysed cells were sonicated (Sonic Dismembranator; Fisher Scientific, Pittsburgh, PA) for 20 s on ice and centrifuged at 1.3 x 104 rpm in a microcentrifuge (Eppendorf, Hamburg, Germany) for 15 minutes. The resulting lysates were either incubated with the M2 beads conjugated to an anti-Flag antibody (Sigma) or GammaBind Plus Sepharose beads (Amersham Biosciences) and the indicated primary antibodies, with addition of 10% (v/v) glycerol to the lysates, and rotated at 30 rpm at 4°C for 2 hours. The beads were collected by brief centrifugation and washed three times with washing buffer (the lysis buffer supplemented with 10% glycerol). To detect the interaction between GST-menin and ASK, cell lysates from 293T cells transfected with pF-ASK were incubated with glutathione beads coupled with either control GST or various GST-menin fusion proteins, in the presence of 10% glycerol (v/v) for 2 hours. The beads were then extensively washed with washing buffer, and proteins on the beads were separated by SDS-PAGE. Immunoblotting analysis using the M2 antibody was performed to detect the association with ASK.
To detect menin, menin mutant, and ASK protein expression in retrovirally transduced menin-null cells, whole-cell lysates were prepared with whole-cell lysis buffer [50 mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.5), 0.4% Triton X-100, 0.1% NP40, 150 mmol/L NaCl, 10 mmol/L MgCl2, 0.5 mmol/L EDTA, 2.5 mmol/L EGTA, 0.2 mmol/L Na3VO4, 1 mmol/L NaF, 10 mmol/L ß-glycerophosphate, 1 mmol/L dithiothreitol, 0.2 mmol/L phenylmethylsulfonyl fluoride, 4 µg/mL leupeptin, aprotenin, and pepstatin A]. The primary antibody against a human menin peptide was raised in rabbits and affinity purified with the corresponding peptide-conjugated agarose beads (17)
. Endogenous ASK was detected by an affinity purified rabbit antihuman ASK antibody (19)
. An antiactin antibody was used as a loading control (Santa Cruz Biotechnology, Santa Cruz, CA). The enhanced chemiluminescence system (Amersham Biosciences) was used, as described previously (17)
.
Production of Glutathione S-TransferaseMenin Proteins.
Exponentially growing DH5
Escherichia coli cells containing various GST-menin constructs were induced with 150 µmol/L isopropyl-1-thio-ß-D-galactopyranoside at room temperature. Bacteria were collected and lysed at 4°C in 1x PBS buffer with protease inhibitors and Triton X-100 (1%), followed by sonication. The supernatant from the lysates was incubated with Glutathione Sepharose 4B beads (Amersham Biosciences), and beads were washed extensively with 1x PBS buffer with protease inhibitors.
[3H]Thymidine Incorporation Assays.
Three thousand cells in 200 µL of MEF medium were seeded per well of a 96-well plate on day 0. On day 3, [3H]thymidine (ICN Biomedicals, Inc., Irvine, CA) was added to the medium. Cells were incubated with [3H]thymidine for 4 hours before being trypsinized and harvested. Incorporation of [3H]thymidine was determined using a model 1450 Microbeta Trillux Scintillation Counter (Wallac, Boston, MA) as described previously (25)
. All samples were analyzed in triplicate.
Fluorescence-Activated Cell Sorting Analysis.
On day 0, cells were seeded at a density of 2 x 105 cells/100-mm dish. On day 2, cells were pulsed for 45 minutes with 10 µmol/L 5'-bromo-2'-deoxyuridine-5'-triphosphate (BrDU; Sigma). After harvesting, 10 (6)
cells per sample were fixed in 70% ethanol while vortexing. Cell pellets were washed in washing buffer (PBS plus 0.5% bovine serum albumin), pelleted, and denatured in denaturing solution (3 N HCl and 0.5% Tween-20) for 10 minutes. After pelleting, cells were then incubated with anti-BrDU antibody (PharMingen, San Jose, CA) for 20 minutes, followed by washing and pelleting. Next, fluorescein isothiocyanate-conjugated goat antimouse IgG (PharMingen) antibody was added for 15 minutes. After another washing and pelleting, cells were resuspended in 0.5 mL of propidium iodide (10 µg/mL in PBS; Sigma) and incubated for 30 minutes. Samples were analyzed on a FACSCalibur (Becton-Dickinson, Franklin Lakes, NJ).
In vitro Kinase Assays.
In vitro phosphorylation assays of human Cdc7-ASK kinase were conducted as described previously (24)
.
Statistical Analysis and Quantitation.
SEM bars are calculated using Microsoft Excel. The Students t test was used to determine significance of results.
 |
RESULTS
|
|---|
Targeted Disruption of Menin Enhances Cell Proliferation, whereas Complementation of Menin-Null Cells with Menin Suppresses Cell Proliferation.
Ectopic expression of menin inhibits cell proliferation of Ras-transformed fibroblasts (9)
. However, whether targeted disruption of Men1 alters cell proliferation is unknown. Therefore, we sought to determine the effect of targeted disruption of the Men1 gene on cell proliferation. Murine embryonic fibroblasts were isolated from normal or Men1/ embryos and immortalized. The rates of cell proliferation for wild-type or menin-null immortalized murine embryonic fibroblasts were examined by [3H]thymidine incorporation. Menin is expressed in the Men1 wild-type cells but not in the Men1 knockout cell lines (Fig. 1A
, bottom panel). Fig. 1A
shows that the menin-null cells incorporate 2.5-fold more [3H]thymidine than do the menin-expressing cells (P < 0.0008). This provides genetic evidence for a crucial role of menin in regulating cell proliferation.

View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 1. Targeted disruption of Men1 enhances cell proliferation, whereas complementation of menin-null cells with menin represses proliferation. A. Targeted disruption of Men1 enhances incorporation of [3H]thymidine into menin-null cells. Murine embryonic fibroblasts from wild-type mice (28) or Men1/ mice (21) were seeded in 96-well plates (3 x 103 cells/well) on day 0. On day 3, [3H]thymidine incorporation was quantitated. This is representative of two independent experiments. Expression of menin in the wild-type and menin-null cells was confirmed by immunoblotting analysis with an antimenin antibody (80). *, protein that cross-reacts with the antimenin antibody, serving as an internal loading control. B. Complementation of menin-null cells with menin inhibits incorporation of [3H]thymidine into the menin-null cells. The menin-null cells were infected with either the control retroviruses or menin-expressing retroviruses as described previously (17)
. The expression of menin in complemented cells was confirmed by immunoblotting analysis. Cells were seeded in 96-well plates on day 0, pulsed with [3H]thymidine on day 3, and quantitated as in A. This is representative of four independent experiments. C, time course of cell growth for the menin-null cells and menin-complemented cells. On day 0, menin-null or menin-complemented cells (2 x 105 cells/100-mm dish) were seeded. Duplicate samples of each cell line were counted on days 1 to 4. This is representative of four independent experiments.
|
|
To further confirm the crucial role of menin in repressing cell proliferation, menin-null cells were infected with either control retroviruses or retroviruses expressing wild-type menin. The expression of menin in complemented cells was confirmed by immunoblotting analysis (Fig. 1B
, bottom panel). Fig. 1B
shows that complementation of menin-null cells with wild-type menin lowers the rate of cell proliferation by approximately 2-fold (top panel, P < 0.03). The kinetics of cell proliferation for menin-null cells and menin-complemented cells were also monitored (Fig. 1C)
. The number of menin-null cells is significantly higher than that of the menin-complemented cells, on days 3 and 4 of culture (P < 0.0007 and 0.02, respectively). Collectively, these results reinforce the crucial role of menin in repression of cell proliferation.
Menin Associates with Activator of S-Phase Kinase, the Regulatory Subunit of Cdc7 Kinase.
To explore the mechanism whereby menin inhibits cell proliferation, we attempted to identify menin-interacting proteins, which may shed light on menin-mediated repression of cell proliferation. Cell lysates from control 293 cells and 293 cells expressing Flag epitope-tagged-menin (F-menin) were passed through agarose beads conjugated with an anti-Flag antibody (M2 beads). Menin and menin-interacting proteins were retained on the beads, separated by SDS-PAGE, and stained with Colloid Coomassie Blue. A protein band immediately above menin was observed in F-menin-expressing cells but not in control cells. This band was excised from the gel (Fig. 2A
, Lane 2) and subjected to sequence analysis by mass spectrometry. Peptide sequences from the excised band matched the sequences from human ASK. ASK, a nuclear protein, is an obligatory component of the active Cdc7/ASK kinase, which is essential for cell proliferation in eukaryotic cells (18)
. Additionally, to identify novel menin-interacting proteins, we performed a yeast-two hybrid screen with an E17 murine embryonic library (BD Bioscience, San Jose, CA) and full-length menin. Two clones expressing ASK were identified during the screening, further supporting the interaction between menin and ASK (data not shown).3

View larger version (39K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 2. Identification of ASK as a menin-interacting protein. A. Human embryonic kidney 293 cells stably transfected with either vector or pcDNA3-F-Menin (100 x 150-mm dishes for each) were harvested and lysed, and F-menin and its associated proteins were purified as described in Materials and Methods. The purified proteins were separated on a 6% SDS-PAGE gel, stained with a Colloidal Blue Staining kit, and excised for mass spectrometry analysis. B. Menin interacts with ectopically expressed ASK. 293T cells were transfected with vector, myc-ASK, or F-Menin, as indicated, and subsequently lysed and immunoprecipitated with the M2 beads. The immunoprecipitated proteins were separated by SDS-PAGE and immunoblotted with an anti-myc (9E10) antibody for ASK (top panel). The bottom panels show the expression of transfected ASK and Menin, respectively, from 1% of the input proteins. C, Menin interacts with endogenous ASK. 293 cells stably transfected with either vector or pF-menin were lysed, immunoprecipitated with the M2 beads, and immunoblotted with an anti-ASK antibody (top panel). The middle panel shows 1% of input immunoblotted with an antimenin antibody. The bottom panel shows 1% of input immunoblotted with an anti-ASK antibody. *, nonspecific cross-reactive band.
|
|
We performed additional experiments to confirm the interaction between menin and ASK. Myc-tagged ASK and Flag-tagged menin were cotransfected into cells, and the resulting cell lysates were immunoprecipitated with the M2 beads. The immunoprecipitated proteins were immunoblotted with the antibody for ASK. Menin indeed interacts with ASK (Fig. 2B
, top panel, Lane 3). As a control, immunoblotting confirmed the expression of ASK and menin (Fig. 2B
, bottom panels). To demonstrate that menin interacts with endogenous ASK, cell lysates from cells stably expressing the epitope-tagged menin were incubated with the M2 beads, and the immunoprecipitated proteins were subjected to immunoblotting analysis. Fig. 2C
shows that endogenous ASK is immunoprecipitated by menin, indicating that menin interacts with endogenous ASK (top panel, Lane 2). The expression of ASK and menin was confirmed by immunoblotting (Fig. 2C
, bottom panels).
Activator of S-Phase Kinase Associates with the COOH Terminus of Menin.
To determine which domain of menin interacts with ASK, we expressed and purified GST fusion proteins containing either the NH2 terminus (F1), the middle region (F2), or the COOH terminus (F3) of menin (Fig. 3A)
. Expression of the various fusion proteins was confirmed by Coomassie Blue staining (Fig. 3B)
. Control GST or various GST-menin fusion proteins were incubated with cell lysates containing the epitope tagged-ASK, and the interaction of ASK with the fusion proteins was detected by immunoblotting analysis. Fig. 3C
(Lane 4) shows that ASK specifically interacts with the COOH terminus (F3), spanning amino acid residues 396 to 610, but does not interact with the control GST or other regions of menin (Lanes 13).

View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 3. ASK interacts with the COOH terminus of menin. A, diagram of GST-menin fusion proteins derived from various fragments of menin. B, Coomassie Blue staining of purified GST, GST-F1, GST-F2, and GST-F3, 2 µg each. C. ASK specifically interacts with the COOH terminus of menin. Glutathione beads coupled to each of the above proteins (2 µg) were incubated with cell lysates (400 µg) containing F-ASK, and the proteins associating with the GST-fusion proteins were pulled down and immunoblotted with an anti-Flag-ASK antibody.
|
|
Disease-Related Mutations in the COOH Terminus of Menin Block the Interaction between Menin and Activator of S-Phase Kinase.
Greater than 63% of Men1 mutations lead to the loss of the COOH terminus from menin (1)
. Given that the COOH terminus of menin interacts with ASK, we determined whether mutations in the COOH terminus of menin disrupt binding of menin to ASK. To this end, we introduced two MEN1-related mutations, 527X and 558X (1)
, into the GST-menin fusion protein (F3; Fig. 4A
). Expression of the wild-type and mutant fusion proteins was confirmed by Coomassie Blue staining (Fig. 4B)
. The ability of menin and menin truncation mutants to bind ASK was examined as described above. Fig. 4C
shows that the wild-type COOH terminus of menin interacts with ASK (Lane 2); however, neither 527X nor 558X interacts with ASK (Lanes 3 and 4). Therefore, two independent disease-related mutations in menin compromise the interaction between menin and ASK.

View larger version (25K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 4. Disease-related menin mutants fail to bind ASK. A, diagram of disease-related mutations. B, Coomassie Blue staining of purified GST, GST-F3, GST-F3m1, and GST-F3m2, 2 µg each, which were used to pull down F-ASK from cell lysates. C. Disease-related mutations in the COOH terminus of menin block the interaction between menin and ASK. Glutathione beads coupled with each of the above proteins (2 µg) were incubated with cell lysates containing F-ASK, and proteins associating with the GST-fusion proteins were pulled down and immunoblotted with an anti-Flag-ASK antibody, as described in Fig. 3
. D. In vitro phosphorylation assays of Cdc7-ASK were conducted with MCM2-4-6-7 protein (0.25 µg) as a substrate. Products were analyzed on a 7.5% gel, and silver-staining pattern (top) and autoradiogram (bottom) are presented. Increasing amounts of purified menin were added (Lanes 37). Amounts of menin added were 0.13 µg (Lane 3), 0.25 µg (Lanes 4 and 8), 0.5 µg (Lanes 1 and 5), 1 µg (Lane 6), and 2.5 µg (Lane 7).
|
|
We further examined whether menin might affect the kinase activity of Cdc7-ASK in vitro, using purified Cdc7, ASK, and MCM substrates. Fig. 4D
shows that MCM2 is vigorously phosphorylated by Cdc-7-ASK, as are MCM4 and MCM6 (top panel, Lane 2). However, addition of increasing amounts of menin does not affect the ability of Cdc-7-ASK to phosphorylate MCM2 (Fig. 4D
, top panel, Lanes 38). Menin is weakly phosphorylated by Cdc7-ASK, but the significance of this is unknown. Fig. 4D
(bottom panel) shows silver staining for proteins used for the in vitro kinase assay. It is possible that menin may affect the interaction of ASK with other important, but unknown, substrates. Alternatively, the interaction between menin and ASK may affect additional functions of ASK other than its Cdc7-associated activity.
Menin Suppresses Activator of S-Phase Kinase-Mediated Stimulation of Cell Proliferation.
Because menin and ASK interact specifically, we sought to determine whether menin interferes with the function of ASK in cell proliferation. We infected menin-null cells with control retroviruses or retroviruses expressing ASK and menin, separately or in various combinations. Fig. 5A
shows that expression of ASK leads to a modest yet consistent increase in the proliferation of menin-null cells, whereas expression of menin inhibits cell proliferation. Interestingly, coexpression of ASK and menin suppresses ASK-mediated stimulation of cell growth (Fig. 5A)
. The levels of expression for both menin and ASK are shown in Fig. 5B
. Collectively, these results indicate that menin can suppress ASK-mediated stimulation of cell proliferation.

View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 5. Menin suppresses ASK-mediated stimulation of cell proliferation. A. Menin-null cells were infected with vector retroviruses or retroviruses expressing Flag-tagged ASK and/or menin, as described in Materials and Methods. The cells were set up in triplicate and counted on day 4. This is representative of three independent experiments. B. Cell lysates from the cells indicated in A were separated by SDS-PAGE and blotted with an antimenin, anti-Flag-ASK (M2), or antiactin antibody, as indicated.
|
|
MEN1-Related Mutations, Which Compromise Interactions with Activator of S-Phase Kinase, Abrogate the Ability of Menin to Suppress Activator of S-Phase Kinase-Mediated Stimulation of Cell Proliferation.
Because MEN1-related mutations of menin in the COOH terminus block the ASK-menin interaction and menin represses ASK-mediated induction of cell proliferation, we determined whether the truncated COOH-terminal portion of menin from MEN1 patients is crucial for inhibiting the ASK-mediated stimulation of cell proliferation. Menin-null cells were infected with retroviruses expressing various combinations of vector, ASK, wild-type menin, and menin mutants, as shown in Fig. 6A
. Consistent with the observation in Fig. 5A
, ASK induces cell proliferation, and menin represses ASK-induced proliferation (Fig. 6A)
. Notably, the COOH-terminal menin mutants, 527X and 558X, fail to repress the ASK-mediated induction of cell proliferation. ASK and menin were all expressed as detected by Western blotting analysis (Fig. 6B)
. Together, these results indicate that loss of the ASK-interacting domain in the COOH terminus of menin deprives menin of the ability to repress ASK-induced cell proliferation. They suggest that menin may repress cell proliferation, at least in part, through interaction with ASK at its COOH terminus. Loss of function of the MEN1-derived menin mutants suggests a potential role for the menin-ASK interaction in regulating the development of MEN1.

View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 6. MEN1-related mutants, which fail to interact with ASK, fail to suppress ASK-mediated stimulation of cell proliferation, but do not display obvious differences in cell cycle profiles. A. Menin-null cells were infected with vector retroviruses, or retroviruses expressing Flag-tagged ASK, wild-type menin, mutant 527X, or mutant 558X, as indicated. The cells were seeded and counted as described in Fig. 5A
. This is representative of three independent experiments. B. Detection of the expression of ASK, menin, and menin mutants is as described in Fig. 5B
. *, nonspecific cross-reactive band. C, cell cycle profiles of menin-null murine embryonic fibroblasts expressing various combinations of vector, ASK, and wild-type or mutant menin. Menin-null murine embryonic fibroblasts infected with vector, ASK, ASK and menin, ASK and 527X, and ASK and 558X were seeded at a density of 2 x 105 cells/100-mm dish and allowed to grow for 48 hours. Cells were then processed and stained with propidium iodide and anti-BrDU antibody as described in Materials and Methods. This is representative of two independent experiments.
|
|
Ectopic Expression of Activator of S-Phase Kinase, Menin, and Various Menin Mutants Does Not Obviously Alter Steady Cell Cycle Profiles.
Using fluorescence-activated cell scanning analysis of cells doubly stained with propidium iodide and the BrDU antibody, we further examined the cell cycle profiles of cells expressing vector, ASK, or ASK plus wild-type or mutant menin, as indicated in Fig. 6C
. Under these conditions, we failed to observe a significant difference among the various cell lines (Fig. 6C)
. It is possible that menin does decrease cell proliferation by slightly altering the cell cycle but that this assay is not sensitive enough to detect such differences. Alternatively, it is also possible that ASK and menin affect one or more phases of the cell cycle, which makes detection of an obvious difference in cell cycle more difficult.
 |
DISCUSSION
|
|---|
The current studies demonstrate a critical role for menin in the inhibition of cell proliferation and uncover a specific interaction between menin and ASK, a crucial regulatory component of Cdc7/ASK that is essential for cell proliferation (18)
. Ectopic overexpression of menin represses the proliferation of Ras-transformed NIH3T3 cells and human insulinoma cells (9
, 10) . We extend these findings by showing that targeted disruption of Men1 enhances cell proliferation, and complementation of menin-null cells with menin represses cell proliferation (Fig. 1)
. These results provide genetic evidence for the critical role of menin in regulating cell proliferation. They suggest that one way in which menin suppresses tumorigenesis may be its inhibition of cell proliferation.
The current studies demonstrate a physical interaction between menin and ASK (Fig. 2)
, and suggest that menin and ASK cooperate in the regulation of cell proliferation. Whereas the NH2 terminus and middle region of menin mediate the interaction with proteins including JunD, nuclear factor-
B, Pem, RPA2, FancD2, and mSin3A (13
, 14
, 16
, 17
, 26
, 27)
, we show that the COOH terminus of menin mediates the specific interaction with ASK (Fig. 3)
. The fact that various domains of menin interact with different proteins may partly explain how menin regulates diverse cellular functions, including gene transcription, genome stability, and cell proliferation.
Importantly, two disease-related COOH-terminal mutations, 527X and 558X, lose the ability to interact with ASK (Fig. 4)
, suggesting a potentially critical role for the interaction between ASK and menin in repressing MEN1 development. The specific interaction between menin and ASK provides a potential mechanistic link between menin and the regulation of cell proliferation. ASK is essential for cell proliferation, and a neutralized antibody against ASK blocks cell proliferation after microinjection into cells (19)
. Consistent with this observation, the expression of ASK alone leads to enhanced proliferation of menin-null cells, whereas coexpression of menin and ASK inhibits proliferation (Fig. 5)
. In other words, the role of ASK in inducing cell proliferation depends on the status of menin in cells; ASK induces cell proliferation in the absence of menin, whereas such a role is inactivated in the presence of menin. In this regard, it is interesting to note that JunD, a transcription factor that interacts with menin, inhibits cell proliferation in the presence of menin but promotes cell growth in the absence of menin (28)
. It is not yet clear whether JunD and ASK functionally interact. Collectively, our studies suggest that menin interacts with ASK and thus represses the role of ASK in stimulating cell proliferation.
If the interaction between menin and ASK is crucial for the ability of menin to repress ASK-mediated cell growth, then mutants of menin that do not bind ASK should fail to inhibit ASK-induced cell proliferation. In fact, two disease-related mutations that cannot bind ASK do fail to inhibit ASK-induced cell proliferation (Fig. 6)
. Thus, the COOH terminus of menin, through its interaction with ASK, may play a crucial role in regulating cell proliferation. In agreement with this notion, approximately 63% of reported germ line and sporadic mutations are truncations that eventually lead to removal of the COOH terminus (1)
. These results strongly suggest that the menin-ASK interaction is functionally important for the role of menin in regulating cell proliferation. However, these results do not rule out that additional pathways are also involved in menin-mediated regulation of cell proliferation.
The exact mechanism by which menin and ASK work together to modulate cell proliferation requires additional study. In vitro biochemical assays show that ASK is essential for Cdc7 protein kinase activity (24)
. Furthermore, yeast Cdc7 and Dbf4, a homologue of ASK, are crucial for DNA replication (18)
. These findings suggest that ASK and menin might influence proliferation via modulation of the cell cycle. Although infection of menin-null cells with ASK resulted in a moderate, but reproducible, increase in cell number, which was completely suppressed by menin, but not by the two COOH-terminal mutants, no obvious differences in cell cycle profiles were seen between the menin-null cells and the cells ectopically expressing ASK. It is possible that PI/BrDU staining is not sensitive enough to detect these differences in our system. Alternatively, it is also possible that ASK and menin affect one or more phases of the cell cycle, which makes detection of an obvious difference in cell cycle more difficult. Moreover, it remains unclear whether the major role of ASK in mammalian cells is the regulation of cell cycle progression, because overexpression of both Cdc7/ASK fails to alter the cell cycle profile (29)
. Recent data show that loss of mammalian Cdc7 function leads to rapid arrest of replication forks, followed by G2-M arrest and eventual apoptosis (30)
. Thus, in mammalian cells, the ASK/Cdc7 complex may not solely influence proliferation of cells by regulating DNA replication. No matter what the detailed mechanisms are, the current findings have provided a link between menin and ASK in the regulation of cell proliferation.
 |
ACKNOWLEDGMENTS
|
|---|
We thank Dr. Chao-Xing Yu at the Proteomics Core Facility at the University of Pennsylvania for performing mass spectrometry analysis.
 |
FOOTNOTES
|
|---|
Grant support: Howard Temin Award 1K01CA78592, Burroughs Wellcome Career Award for Biomedical Research 1676, the Rita Allen Foundation, and NIH grant RO1 CA100912.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Requests for reprints: Xianxin Hua, Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104-6160. Phone: 215-746-5565; Fax: 215-746-5525; E-mail: huax{at}mail.med.upenn.edu
3 Z. Hou, unpublished data. 
Received 2/27/04.
Revised 7/ 2/04.
Accepted 7/12/04.
 |
REFERENCES
|
|---|
- Pannett AA, Thakker RV. Multiple endocrine neoplasia type 1. Endocr Relat Cancer, 1999;6:449-73, [Abstract]
- Marx SJ. Multiple endocrine neoplasia type I Vogelstein B Kinzler KW eds. . The genetic basis of human cancer, 1998489-506, McGraw-Hill New York
- Chandrasekharappa SC, Guru SC, Manickam P, et al Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science, 1997;276:404-7, [Abstract/Free Full Text]
- Crabtree JS, Scacheri PC, Ward JM, et al A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA, 2001;98:1118-23, [Abstract/Free Full Text]
- Crabtree JS, Scacheri PC, Ward JM, et al Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol, 2003;23:6075-85, [Abstract/Free Full Text]
- Libutti SK, Crabtree JS, Lorang D, et al Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res, 2003;63:8022-8, [Abstract/Free Full Text]
- Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol, 2003;17:1880-92, [Abstract/Free Full Text]
- Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX, Wang ZQ. Pancreatic ß-cellspecific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res, 2003;63:4836-41, [Abstract/Free Full Text]
- Kim YS, Burns AL, Goldsmith PK, et al Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene, 1999;18:5936-42, [CrossRef][Medline]
- Sayo Y, Murao K, Imachi H, et al The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology, 2002;143:2437-40, [Abstract]
- Lin S, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell, 2003;113:881-9, [CrossRef][Medline]
- Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type ß signaling. Proc Natl Acad Sci USA, 2001;98:3837-42, [Abstract/Free Full Text]
- Heppner C, Bilimoria KY, Agarwal SK, et al The tumor suppressor protein menin interacts with NF-
B proteins and inhibits NF-
Bmediated transactivation. Oncogene, 2001;20:4917-25, [CrossRef][Medline]
- Agarwal SK, Guru SC, Heppner C, et al Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell, 1999;96:143-52, [CrossRef][Medline]
- Poisson A, Zablewska B, Gaudray P. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett, 2003;189:1-10, [CrossRef][Medline]
- Sukhodolets K, Hickman A, Agarwal SK, et al The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol, 2003;23:493-509, [Abstract/Free Full Text]
- Jin S, Mao H, Schnepp RW, et al Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res, 2003;63:4204-10, [Abstract/Free Full Text]
- Masai H, Arai K. Cdc7 kinase complex: a key regulator in the initiation of DNA replication. J Cell Physiol, 2002;190:287-96, [CrossRef][Medline]
- Kumagai H, Sato N, Yamada M, et al A novel growth- and cell cycleregulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells. Mol Cell Biol, 1999;19:5083-95, [Abstract/Free Full Text]
- Agarwal SK, Kester MB, Debelenko LV, et al Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet, 1997;6:1169-75, [Abstract/Free Full Text]
- Hua X, Liu X, Ansari DO, Lodish HF. Synergistic cooperation of TFE3 and smad proteins in TGF-ßinduced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev, 1998;12:3084-95, [Abstract/Free Full Text]
- Schnepp RW, Mao H, Sykes SM, et al Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem, 2004;279:10685-91, [Abstract/Free Full Text]
- Hua X, Nohturfft A, Goldstein JL, Brown MS. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell, 1996;87:415-26, [CrossRef][Medline]
- Masai H, Matsui E, You Z, Ishimi Y, Tamai K, Arai K. Human Cdc7-related kinase complex: in vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 bY Cdks. J Biol Chem, 2000;275:29042-52, [Abstract/Free Full Text]
- La P, Morgan T, Sykes S, et al Fusion proteins of retinoid receptors antagonize TGF-ßinduced growth inhibition of lung epithelial cells. Oncogene, 2003;22:198-210, [CrossRef][Medline]
- Kim H, Lee JE, Cho EJ, Liu JO, Youn HD. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res, 2003;63:6135-9, [Abstract/Free Full Text]
- Lemmens IH, Forsberg L, Pannett AA, et al Menin interacts directly with the homeobox-containing protein Pem. Biochem Biophys Res Commun, 2001;286:426-31, [CrossRef][Medline]
- Agarwal SK, Novotny EA, Crabtree JS, et al Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci USA, 2003;100:10770-5, [Abstract/Free Full Text]
- Sato N, Sato M, Nakayama M, Saitoh R, Arai K, Masai H. Cell cycle regulation of chromatin binding and nuclear localization of human Cdc7-ASK kinase complex. Genes Cells, 2003;8:451-63, [Abstract]
- Kim JM, Yamada M, Masai H. Functions of mammalian Cdc7 kinase in initiation/monitoring of DNA replication and development. Mutat Res, 2003;532:29-40, [Medline]
This article has been cited by other articles:

|
 |

|
 |
 
A. Matoso, Z. Zhou, R. Hayama, A. Flesken-Nikitin, and A. Yu. Nikitin
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia
Carcinogenesis,
March 1, 2008;
29(3):
620 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. La, Y. Yang, S. K. Karnik, A. C. Silva, R. W. Schnepp, S. K. Kim, and X. Hua
Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1
J. Biol. Chem.,
October 26, 2007;
282(43):
31332 - 31340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Busygina, M. C. Kottemann, K. L. Scott, S. E. Plon, and A. E. Bale
Multiple Endocrine Neoplasia Type 1 Interacts with Forkhead Transcription Factor CHES1 in DNA Damage Response.
Cancer Res.,
September 1, 2006;
66(17):
8397 - 8403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Schnepp, Y.-X. Chen, H. Wang, T. Cash, A. Silva, J. A. Diehl, E. Brown, and X. Hua
Mutation of Tumor Suppressor Gene Men1 Acutely Enhances Proliferation of Pancreatic Islet Cells
Cancer Res.,
June 1, 2006;
66(11):
5707 - 5715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Milne, C. M. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-Rosen, Y. Dou, R. W. Schnepp, C. Krankel, V. A. LiVolsi, D. Gibbs, et al.
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
PNAS,
January 18, 2005;
102(3):
749 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. La, A. C. Silva, Z. Hou, H. Wang, R. W. Schnepp, N. Yan, Y. Shi, and X. Hua
Direct Binding of DNA by Tumor Suppressor Menin
J. Biol. Chem.,
November 19, 2004;
279(47):
49045 - 49054.
[Abstract]
[Full Text]
[PDF]
|
 |
|